Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Vaccines and Molecular Therapeutics

Antibodies directed against extracellular loops of FadL orthologs disrupt outer membrane integrity and neutralize infectivity of Treponema pallidum, the syphilis spirochete

Provisionally accepted
Kristina  Nicole DelgadoKristina Nicole Delgado1Crystal  F. VicenteCrystal F. Vicente1Carson  J. La VakeCarson J. La Vake1Melissa  Jo CaimanoMelissa Jo Caimano1Justin  David RadolfJustin David Radolf1,2Kelly  Lynn HawleyKelly Lynn Hawley1,2*
  • 1University of Connecticut Health Center, Farmington, United States
  • 2Connecticut Children's, Hartford, United States

The final, formatted version of the article will be published soon.

ABSTRACT A vaccine is urgently needed to curtail the global epidemic of syphilis, a sexually transmitted infection caused by the spirochetal pathogen Treponema pallidum (TPA). Protective antibodies must target extracellular loops (ECLs) of TPA outer membrane proteins (OMPs). Immune rabbit serum (IRS) and antibodies elicited by immunization with a Pyrococcus furiosus thioredoxin (PfTrx) scaffold displaying ECLs from BamA (TP0326) and three FadLs (TP0856, TP0858 and TP0865) inhibited growth and metabolic activity of spirochetes during in vitro cultivation. Flow cytometric analysis of GFP-expressing TPA using the membrane impermeable dye propidium iodide revealed that IRS and growth-inhibiting ECL-specific antibodies disrupted the spirochete's fragile outer membrane. Spirochetes incubated with IRS or growth-inhibiting ECL-specific antibodies produced no or only transient lesions with markedly reduced bacterial burdens following intradermal inoculation into rabbits, confirming neutralization of infectivity. This study advances efforts to define immune correlates of protection to guide rational development of a multivalent, ECL-based syphilis vaccine.

Keywords: Syphilis, Treponema pallidum, fadL, Extracellular loop, in vitro, outer membranedamage, Growth inhibition

Received: 14 Oct 2025; Accepted: 11 Nov 2025.

Copyright: © 2025 Delgado, Vicente, La Vake, Caimano, Radolf and Hawley. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Kelly Lynn Hawley, hawley@uchc.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.